Development of reconstructed intestinal micronucleus cytome (RICyt) assay in 3D human gut model for genotoxicity assessment of orally ingested substances

5Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The micronucleus (MN) assay is widely used as part of a battery of tests applied to evaluate the genotoxic potential of chemicals, including new food additives and novel food ingredients. Micronucleus assays typically utilise homogenous in vitro cell lines which poorly recapitulate the physiology, biochemistry and genomic events in the gut, the site of first contact for ingested materials. Here we have adapted and validated the MN endpoint assay protocol for use with complex 3D reconstructed intestinal microtissues; we have named this new protocol the reconstructed intestine micronucleus cytome (RICyt) assay. Our data suggest the commercial 3D microtissues replicate the physiological, biochemical and genomic responses of native human small intestine to exogenous compounds. Tissues were shown to maintain log-phase proliferation throughout the period of exposure and expressed low background MN. Analysis using the RICyt assay protocol revealed the presence of diverse cell types and nuclear anomalies (cytome) in addition to MN, indicating evidence for comprehensive DNA damage and mode(s) of cell death reported by the assay. The assay correctly identified and discriminated direct-acting clastogen, aneugen and clastogen requiring exogenous metabolic activation, and a non-genotoxic chemical. We are confident that the genotoxic response in the 3D microtissues more closely resembles the native tissues due to the inherent tissue architecture, surface area, barrier effects and tissue matrix interactions. This proof-of-concept study highlights the RICyt MN cytome assay in 3D reconstructed intestinal microtissues is a promising tool for applications in predictive toxicology.

References Powered by Scopus

Hydrogels as extracellular matrix mimics for 3D cell culture

2260Citations
N/AReaders
Get full text

The micronucleus test

2197Citations
N/AReaders
Get full text

Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability

2149Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report

8Citations
N/AReaders
Get full text

Addressing the safety of new food sources and production systems

4Citations
N/AReaders
Get full text

Revealing the amyloid β-protein with zinc finger protein of micronucleus during Alzheimer's disease progress by a quaternary ammonium terpyridine probe

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lim, H. K., Hughes, C. O., Lim, M. J. S., Li, J. J., Rakshit, M., Yeo, C., … Smith, B. P. C. (2022). Development of reconstructed intestinal micronucleus cytome (RICyt) assay in 3D human gut model for genotoxicity assessment of orally ingested substances. Archives of Toxicology, 96(5), 1455–1471. https://doi.org/10.1007/s00204-022-03228-y

Readers' Seniority

Tooltip

Researcher 3

60%

Professor / Associate Prof. 1

20%

PhD / Post grad / Masters / Doc 1

20%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

40%

Agricultural and Biological Sciences 1

20%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Engineering 1

20%

Save time finding and organizing research with Mendeley

Sign up for free